- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Alzheimer’s disease and immunotherapy ; volume:3 ; number:1 ; day:23 ; month:8 ; year:2024 ; pages:1-16 ; date:12.2024
Current medicine ; 3, Heft 1 (23.8.2024), 1-16, 12.2024
- Urheber
-
Qin, Wei
Pang, Yana
Nie, Shuya
Quan, Meina
Jia, Jianping
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s44194-024-00035-8
- URN
-
urn:nbn:de:101:1-2411120851356.944536013884
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qin, Wei
- Pang, Yana
- Nie, Shuya
- Quan, Meina
- Jia, Jianping
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Alzheimer’s Disease
Endocytosis and Alzheimer’s disease
Immunosenescence, inflammation and Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
Cerebrovascular disease in ageing and Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Alzheimer’s Disease
Endocytosis and Alzheimer’s disease
Immunosenescence, inflammation and Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model
Cerebrovascular disease in ageing and Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Alzheimer’s Disease
Endocytosis and Alzheimer’s disease
Immunosenescence, inflammation and Alzheimer’s disease
Alzheimer’s disease and gut microbiota
Microglial motility in Alzheimer’s disease and after Aβ42 immunotherapy: a human post-mortem study
Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse model